Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Lupus. 2020 Dec;29(14):1971-1977. doi: 10.1177/0961203320961474. Epub 2020 Sep 30.
Mortality in SLE has a bimodal peak with early deaths mainly related to disease activity and infection. Although mortality has reduced over years, it is still two to three folds compared to the general population. In India due to increased burden of infection and limited access to health care, the causes may be different.
Retrospective, review of records of all adult SLE patients fulfilling ACR 1997 criteria, who died in hospital between 2000-2019 at a teaching hospital in India was done. In addition, baseline clinical features were extracted for all adult SLE patients seen during this period.Infections were either bacteriologically proven or based on clinicradiological or serologic evidence. Active disease was defined as SLEDAI 2k ≥ 5. Logistic regression was performed to ascertain risk factors for mortality.
A total of 1337 (92% females) patient records were reviewed .The mean age at presentation was 29.9 ± 9 years.60-75% of patients had fever, mucocutaneous disease and arthritis, while nephritis, hematologic, serositis and neurologic involvement was seen in 48.6%, 43.2%, 16% and 10.3% respectively as presenting mainfestations. There were 80 in hospital deaths .Infection was the most common cause of death, with 37 due to infection alone and in 24 disease activity also contributed. Only 18 deaths were due to active disease. Among bacterial infections lung was the most common site and gram negative organism were the most common pathogens. There were 10 deaths due to Tuberculosis(TB) and half of them had disseminated disease. Patients with disease activity had a SLEDAI of 14.8 ± 6.4, with neurological, renal and cardiovascular involvement being the major contributors to mortality in 11, 7 and 6 cases respectively. Higher age at onset, male gender, fever, myositis, neurological, cardiovascular, gastrointestinal involvement, vasculitis, elevated serum creatinine at baseline were independent predictors of death.
Infections are the most common cause of in-hospital mortality in SLE and TB still accounts for 15% of deaths related to infection. Vasculitis, myositis, cardiovascular and gastrointestinal involvement emerged as novel predictors of mortality in our cohort.
SLE 患者的死亡率呈双峰分布,早期死亡主要与疾病活动和感染有关。尽管多年来死亡率有所下降,但仍比普通人群高出两到三倍。在印度,由于感染负担增加和医疗保健获取受限,原因可能有所不同。
对 2000 年至 2019 年期间在印度一家教学医院住院期间死亡的符合 ACR 1997 标准的所有成年 SLE 患者的病历进行回顾性分析。此外,还提取了在此期间就诊的所有成年 SLE 患者的基线临床特征。感染要么通过细菌学证实,要么基于临床放射学或血清学证据。活动期疾病定义为 SLEDAI 2k≥5。进行逻辑回归以确定死亡率的危险因素。
共回顾了 1337 份(92%为女性)患者记录。就诊时的平均年龄为 29.9±9 岁。60-75%的患者有发热、黏膜皮肤疾病和关节炎,而肾炎、血液学、浆膜炎和神经系统受累分别见于 48.6%、43.2%、16%和 10.3%。有 80 例院内死亡。感染是最常见的死亡原因,单纯感染导致 37 例死亡,24 例疾病活动也有贡献。仅有 18 例死亡是由活动期疾病引起的。在细菌性感染中,肺部是最常见的部位,革兰氏阴性菌是最常见的病原体。有 10 例死亡是由结核病(TB)引起的,其中一半患者有播散性疾病。有疾病活动的患者 SLEDAI 为 14.8±6.4,其中 11 例、7 例和 6 例分别与神经系统、肾脏和心血管受累有关。发病年龄较大、男性、发热、肌炎、神经系统、心血管、胃肠道受累、血管炎、基线时血清肌酐升高是死亡的独立预测因素。
感染是 SLE 患者住院期间死亡的最常见原因,结核病仍然占与感染相关的死亡的 15%。在我们的队列中,血管炎、肌炎、心血管和胃肠道受累成为死亡率的新预测因素。